Khalid O Dar, MD
- ASSISTANT PROFESSOR | Medicine, Hematology and Medical Oncology
Specialties:Cancer (Oncology), Hematology-Oncology
I have been on staff at St. Luke’s Hospital since 1995 and have dedicated almost my entire career in serving the patients and community of St. Luke’s. I was initially involved in training fellows in the Hematology/Oncology fellowship program at St. Luke’s Hospital and subsequently served as a voluntary attending physician in private practice.
I am proud of the affiliation with Mount Sinai particularly now that the Tisch Cancer Institute at Mount Sinai has received NCI designation as a Clinical Cancer Center. I have always been focused on providing personalized, compassionate care and now with the close association with Mount Sinai my patients will have access to the most up-to-date research, diagnostic tools and therapies available.
- Breast Cancer
- Colorectal Cancer
- Gastric (Stomach) Cancer
- Hematologic Malignancies
- Lung Cancer
- Myelodysplastic Syndromes
- Myeloproliferative Disorders
- Pancreatic Cancer
- Prostate Cancer
MBBS, Westminster Medical School
Residency, Surgery, Queen Mary's Hospital
Residency, Internal Medicine, Staten Island University Hospital
Fellowship, Hematology-Oncology, NYU Langone Medical Center
As a fellow my research project focused on the drug development of the topoisomerase I inhibitor topotecan. Using Western Blot assays I quantified the topoisomerase I copy numbers in a variety of human tumors to identify potential cancers that may be susceptible to this therapy. I was also involved in developing a mouse in vivo system for combination immuno-chemotherapy using xenografts of human mammary tumors in mice.